Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Sackler

Supreme Court Halts Purdue Pharma’s $6B Settlement From A Challenge In A Lawsuit

The Supreme Court temporarily blocked a bankruptcy settlement by Purdue Pharma that would shield victims from civil lawsuits.

Zenger

Supreme Court blocks Purdue Pharma bankruptcy deal that shields Sackler family from lawsuits

Justices will hear arguments in the case in December

The Independent UK

Supreme Court temporarily blocks $6 billion Purdue Pharma-Sackler bankruptcy

Supreme Court's decision to review the controversial bankruptcy deal involving the maker of Oxycontin means the settlement will remain on hold at least through December.

WEKU

From analysis to the latest developments in health,
read the most diverse news in one place.

Painkiller review – Matthew Broderick’s character is just evil

The actor’s role as the head of the company behind the opioid crisis isn’t the most rewarding, but this drama is furious, unflinching TV. Its horrifying story should be heard again and again

The Guardian - UK

8 of the best true crime books of all time

Graduate from podcasts and YouTube deep-dives

Evening Standard

British Museum urged to remove BP’s name from lecture theatre

Over 80 public figures tell museum’s director it would send a ‘powerful message’ on fossil fuel sponsorship

The Guardian - UK

Court says OxyContin maker's bankruptcy and protections for Sackler family members can move ahead

OxyContin maker Purdue Pharma can start its transformation under a bankruptcy agreement that allows the members of the wealthy Sackler family who own the company to avoid civil lawsuits over the opioid crisis, a court has ruled

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Afternoon Update: RBA governor suggests more share houses; inflation rises; and vapour blasts from a Saturn moon

Underlying inflation and price pressures easing, shrinking the likelihood of another RBA rate hike on Tuesday

The Guardian - AU

A landmark appeals court ruling clears way for Purdue Pharma-Sackler bankruptcy deal

The 2nd Circuit Court of Appeals in New York cleared the way for a controversial bankruptcy deal that grants immunity from opioid lawsuits to members of the Sackler family.

WEKU

Ruling clears way for Purdue Pharma to settle opioid claims, protect Sacklers from lawsuits

A federal court ruling has cleared the way for OxyContin maker Purdue Pharma to settle thousands of legal claims over the toll of opioids

The Independent UK

Scandal-plagued Sackler pharma family’s name axed from Oxford University over role in opioid crisis

A number of institutions have ended their relationships with the Sackler family over its association with the US opioid crisis

The Independent UK

Oxford University cuts ties with Sackler family over links with opioids

University follows other institutions in removing titles of family who make OxyContin painkiller

The Guardian - UK

Oxford University drops Sackler name from buildings and staff posts after review

A number of institutions have ended their relationships with the Sackler family over its association with the US opioid crisis.

The Independent UK

Frustration grows over wait on OxyContin maker's settlement

More than a year after the maker of OxyContin reached a tentative settlement over the toll of opioids, the money isn't flowing yet

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

New this week: 'Top Gun,' Lana Del Rey and 'Rabbit Hole'

This week’s new entertainment releases include fresh albums from Lana Del Rey and Ellie Goulding, the landing of “Top Gun: Maverick” on Paramount+ and a TV show centered on an FBI agent who gets pulled into danger and secret missions aboard “The Night Agent” streams on Netflix

ABC News

All the Beauty and the Bloodshed shows Nan Goldin's fight to hold the Sacklers accountable for role in opioid crisis

Photographer Nan Goldin became addicted to OxyContin after it was prescribed for an injury; a new movie shows her quest to hold the corporation behind the US opioid crisis accountable.

The Independent UK

Nan Goldin is going to the Oscars, and she wants to win

It’s not always emphasized given that she’s one of the most groundbreaking still photographers of the past 50 years

The Guardian - UK

First Sackler, now Bet365. The art world can’t keep taking money from companies that do us harm

Gambling firms shouldn’t be patronising the arts any more than fossil fuel companies, says Guardian columnist Hannah Jane Parkinson

Get all your
news in one place.

100’s of premium titles.
One news app.

Evening Standard

All the Beauty and the Bloodshed director Laura Poitras: “Nan Goldin is doing great things in a dark time”

The film follows the artist and activist in her campaign against the Sackler family and the opioid crisis

The Guardian - UK

All the Beauty and the Bloodshed review – Nan Goldin’s gripping takedown of the Sackler pharma family

Laura Poitras’s Oscar-nominated documentary chronicles the artist’s crusade against the philanthropic US billionaires fuelling of the opioid crisis

The Independent UK

Our weekend arts and culture picks, from The Fabelmans to Happy Valley

Our critics and editors share their expert cultural picks for the next few days

The Independent UK

Our weekend arts and culture picks, from Happy Valley to Florence + The Machine

Our critics and editors share their expert cultural picks for the next few days

Evening Standard

All the Beauty and the Bloodshed review: Nan Goldin documentary will leave you emotionally wrecked

The film weaves the artist’s fight with the Sackler family over the opioid crisis with her own tragic backstory

Evening Standard

Oscars 2023: who will win? And who should win?

All eyes are on this Sunday as the awards race heats up

The Guardian - UK

All the Beauty and the Bloodshed review – Nan Goldin takes on big pharma

Documentary follows Goldin, the artist who became addicted to OxyContin, as she confronts the wealthy art patrons who profited from its sale

1 2 3 4

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.